American International Group’s Aura Biosciences AURA Stock Holding History

American International Group’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,579	Closed	-$138K	–	250
2024 Q1	$138K	Buy	17,579 +3,782	+27%	+$31.4K	﹤0.01%	2350
2023 Q4	$122K	Buy	13,797 +88	+0.6%	+$745	﹤0.01%	2448
2023 Q3	$123K	Buy	13,709 +488	+4%	+$5.25K	﹤0.01%	2394
2023 Q2	$163K	Buy	13,221 +1,805	+16%	+$19.3K	﹤0.01%	2291
2023 Q1	$106K	Buy	11,416 +2,748	+32%	+$28.5K	﹤0.01%	2429
2022 Q4	$91K	Sell	8,668 -32	-0.4%	-$407	﹤0.01%	2558
2022 Q3	$158K	Buy	8,700 +123	+1%	+$1.86K	﹤0.01%	2292
2022 Q2	$122K	Buy	8,577 +5,795	+208%	+$95.9K	﹤0.01%	2467
2022 Q1	$61K	Sell	2,782 -115	-4%	-$2.19K	﹤0.01%	2775
2021 Q4	$49K	Buy	+2,897	New	+$51.8K	﹤0.01%	2962

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

American International Group's AURA Position: Q2 2024 in Review

American International Group sold out of Aura Biosciences (AURA) in Q2 2024, closing a stake of 17,579 shares — an estimated $138K sold.

American International Group first reported a position in AURA in Q4 2021 and held it in 10 quarters. The position peaked at $163K in Q2 2023. 75 funds tracked by Wall St. Rank hold AURA as of Q2 2024.

American International Group reported no remaining Aura Biosciences position as of Q2 2024 after selling out during the quarter.
American International Group sold 17,579 Aura Biosciences shares in Q2 2024, an estimated $138K.
American International Group first reported a position in Aura Biosciences in Q4 2021 and held it in 10 quarters.
American International Group's Aura Biosciences position peaked at $163K in Q2 2023.
75 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.